Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications.

[1]  Jie Wu,et al.  Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  Basappa,et al.  Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK , 2019, International journal of molecular sciences.

[3]  T. Kalinski,et al.  Different Forms of TFF2, A Lectin of the Human Gastric Mucus Barrier: In Vitro Binding Studies , 2019, International journal of molecular sciences.

[4]  M. Nagino,et al.  Trefoil Factor Family 1 Inhibits the Development of Hepatocellular Carcinoma by Regulating β‐Catenin Activation , 2019, Hepatology.

[5]  S. Brierley,et al.  Trefoil Factor Family: Unresolved Questions and Clinical Perspectives. , 2019, Trends in biochemical sciences.

[6]  Lynette M. Smith,et al.  Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer , 2019, EBioMedicine.

[7]  D. Czajkowsky,et al.  Evidence for heightened genetic instability in precancerous spasmolytic polypeptide expressing gastric glands , 2019, Journal of Medical Genetics.

[8]  Y. Chung,et al.  Overexpression of TFF3 is involved in prostate carcinogenesis via blocking mitochondria-mediated apoptosis , 2018, Experimental & Molecular Medicine.

[9]  R. Esposito,et al.  TFF1 Promotes EMT-Like Changes through an Auto-Induction Mechanism , 2018, International journal of molecular sciences.

[10]  D. P. Mishra,et al.  Glycolytic inhibitor 2-Deoxy-d-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway. , 2018, Biochemical and biophysical research communications.

[11]  W. El-Rifai,et al.  Methylation of the HOXA10 Promoter Directs miR-196b-5p–Dependent Cell Proliferation and Invasion of Gastric Cancer Cells , 2018, Molecular Cancer Research.

[12]  R. Barrio,et al.  PPARδ Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth. , 2018, Cancer Research.

[13]  C. Dejong,et al.  Patient‐derived organoid models help define personalized management of gastrointestinal cancer , 2018, The British journal of surgery.

[14]  R. Playford,et al.  Trefoil factor family peptides enhance cell migration by increasing cellular osmotic permeability and aquaporin 3 levels , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  X. Lin,et al.  Lentivirus-mediated shRNA interference of trefoil factor 3 blocks cell viability, migration and invasion in the papillary thyroid carcinoma cells. , 2018, Neoplasma.

[16]  P. Chaiyarit,et al.  Production of Monoclonal Antibodies against Human Trefoil Factor 3 and Development of a Modified-Sandwich ELISA for Detection of Trefoil Factor 3 Homodimer in Saliva , 2017, Biological Procedures Online.

[17]  X. Teng,et al.  MicroRNA-7-5p regulates the proliferation and migration of intestinal epithelial cells by targeting trefoil factor 3 via inhibiting the phosphoinositide 3-kinase/Akt signalling pathway , 2017, International journal of molecular medicine.

[18]  K. D. Sørensen,et al.  Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis , 2017, International journal of molecular sciences.

[19]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. , 2017, Cancer cell.

[20]  Shuo Diao,et al.  Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1α , 2017, Oncotarget.

[21]  H. Stephan,et al.  Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR‐18a regulation , 2017, International journal of cancer.

[22]  W. El-Rifai,et al.  Loss of Tff1 Promotes Pro-Inflammatory Phenotype with Increase in the Levels of RORγt+ T Lymphocytes and Il-17 in Mouse Gastric Neoplasia , 2017, Journal of Cancer.

[23]  Y. Seto,et al.  Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer , 2017, Scientific Reports.

[24]  T. Zhu,et al.  Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent , 2017, Oncotarget.

[25]  R. Einspanier,et al.  Trefoil factor 3 mediates resistance to apoptosis in colon carcinoma cells by a regulatory RNA axis , 2017, Cell Death & Disease.

[26]  M. Montrose,et al.  Trefoil Factor Peptides and Gastrointestinal Function. , 2017, Annual review of physiology.

[27]  R. Einspanier,et al.  TFF3-dependent resistance of human colorectal adenocarcinoma cells HT-29/B6 to apoptosis is mediated by miR-491-5p regulation of lncRNA PRINS , 2017, Cell Death Discovery.

[28]  Dandan Chen,et al.  Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells , 2017, Cancer Cell International.

[29]  K. Lillemoe,et al.  Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice. , 2016, Gastroenterology.

[30]  S. Thiem,et al.  Inducible gene modification in the gastric epithelium of Tff1‐CreERT2, Tff2‐rtTA, Tff3‐luc mice , 2016, Genesis.

[31]  L. Kang,et al.  Quantitative and Qualitative Analysis of Flavonoids and Phenolic Acids in Snow Chrysanthemum (Coreopsis tinctoria Nutt.) by HPLC-DAD and UPLC-ESI-QTOF-MS , 2016, Molecules.

[32]  B. Guleng,et al.  Trefoil factor family 2 expression inhibits gastric cancer cell growth and invasion in vitro via interactions with the transcription factor Sp3 , 2016, International journal of molecular medicine.

[33]  H. Stephan,et al.  Forced Trefoil Factor Family Peptide 3 (TFF3) Expression Reduces Growth, Viability, and Tumorigenicity of Human Retinoblastoma Cell Lines , 2016, PloS one.

[34]  Rajvinder Singh,et al.  Sessile serrated adenoma/polyps: Where are we at in 2016? , 2016, World journal of gastroenterology.

[35]  J. Medema,et al.  Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation. , 2016, Trends in cancer.

[36]  B. Bauer,et al.  C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation , 2016, Journal of Molecular Medicine.

[37]  Xiangdong Deng,et al.  Human Trefoil Factor 3 induces the transcription of its own promoter through STAT3 , 2016, Scientific Reports.

[38]  M. Medvedovic,et al.  The Development of Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) During Gastric Repair Is Absent in the Aged Stomach , 2016, Cellular and molecular gastroenterology and hepatology.

[39]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[40]  N. Nagarajan,et al.  Mutational spectrum of Barrett's stem cells suggests paths to initiation of a precancerous lesion , 2016, Nature Communications.

[41]  S. Sel,et al.  CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1/2 Signaling Pathway. , 2016, Investigative ophthalmology & visual science.

[42]  Bing Liu,et al.  TFF3 knockout in human pituitary adenoma cell HP75 facilitates cell apoptosis via mitochondrial pathway. , 2015, International journal of clinical and experimental pathology.

[43]  Jen Jen Yeh,et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.

[44]  Xianghua Huang,et al.  Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling. , 2015, International journal of clinical and experimental pathology.

[45]  M. Wada,et al.  Involvement of trefoil factor family 2 in the enlargement of intestinal tumors in Apc(Min/+) mice. , 2015, Biochemical and biophysical research communications.

[46]  S. Duffy,et al.  Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma , 2015, Clinical Cancer Research.

[47]  M. Mino‐Kenudson,et al.  Pancreatic duct glands (PDGs) are a progenitor compartment responsible for pancreatic ductal epithelial repair. , 2015, Stem cell research.

[48]  S. Kedia,et al.  Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity. , 2015, Journal of Crohn's & colitis.

[49]  Satyanarayan Rao,et al.  Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets , 2015, Molecular and Cellular Therapies.

[50]  Angharad Evans,et al.  Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation. , 2015, Cancer letters.

[51]  S. Ogino,et al.  TFF2–CXCR4 Axis Is Associated with BRAF V600E Colon Cancer , 2015, Cancer Prevention Research.

[52]  Bruce R Westley,et al.  TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer , 2015, Endocrine-related cancer.

[53]  Zhu Zhu,et al.  Increased Expression of Protease-Activated Receptor 4 and Trefoil Factor 2 in Human Colorectal Cancer , 2015, PloS one.

[54]  K. Nam,et al.  miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach , 2015, Gut.

[55]  D. Barras,et al.  BRAF Mutation in Colorectal Cancer: An Update , 2015, Biomarkers in cancer.

[56]  Sarmed S. Sami,et al.  Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study , 2015, PLoS medicine.

[57]  T. Zima,et al.  Trefoil factor family (TFF) proteins as potential serum biomarkers in patients with metastatic colorectal cancer. , 2015, Neoplasma.

[58]  H. Sugimura,et al.  Extensive goblet cell metaplasia of the peripheral lung may harbor precancerous molecular changes: Comparison of two cases , 2014, Pathology international.

[59]  M. Zhang,et al.  Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma , 2014, Breast Cancer Research.

[60]  F. Hanisch,et al.  Human Trefoil Factor 2 Is a Lectin That Binds α-GlcNAc-capped Mucin Glycans with Antibiotic Activity against Helicobacter pylori* , 2014, The Journal of Biological Chemistry.

[61]  M. Washington,et al.  Activation of β-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis , 2014, Gut.

[62]  W. El-Rifai,et al.  TFF1 activates p53 through down-regulation of miR-504 in gastric cancer , 2014, Oncotarget.

[63]  Yun-peng Liu,et al.  miRNA423-5p regulates cell proliferation and invasion by targeting trefoil factor 1 in gastric cancer cells. , 2014, Cancer letters.

[64]  Zhi-gang Huang,et al.  Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: A monocentric cohort study in China , 2014, BMC Gastroenterology.

[65]  P. Jiang,et al.  Promoter hypermethylation and downregulation of trefoil factor 2 in human gastric cancer , 2014, Oncology letters.

[66]  M. Bronner,et al.  RNA Sequencing of Sessile Serrated Colon Polyps Identifies Differentially Expressed Genes and Immunohistochemical Markers , 2014, PloS one.

[67]  L. Marzullo,et al.  Copper Promotes TFF1-Mediated Helicobacter pylori Colonization , 2013, PloS one.

[68]  Z. Yong,et al.  Kinetic Characterization of an Intestinal Trefoil Factor Receptor , 2013, PloS one.

[69]  T. Insawang,et al.  The trefoil factor 1 (TFF1) protein involved in doxorubicin‑induced apoptosis resistance is upregulated by estrogen in breast cancer cells. , 2013, Oncology reports.

[70]  M. Pera,et al.  Activation of the NF-kB pathway downregulates TFF-1 in gastric carcinogenesis , 2013, Virchows Archiv.

[71]  T. Zhu,et al.  Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis. , 2013, Cancer letters.

[72]  Lewis C Cantley,et al.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy , 2013, Nature Medicine.

[73]  Y. Koga,et al.  Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer. , 2013, International journal of oncology.

[74]  Y. Goshima,et al.  Trefoil factor 2 promotes cell proliferation in pancreatic β-cells through CXCR-4-mediated ERK1/2 phosphorylation. , 2013, Endocrinology.

[75]  F. Hanisch,et al.  Human gastric TFF2 peptide contains an N-linked fucosylated N,N'-diacetyllactosediamine (LacdiNAc) oligosaccharide. , 2013, Glycobiology.

[76]  F. May.  The potential of trefoil proteins as biomarkers in human cancer. , 2012, Biomarkers in medicine.

[77]  Hanlin L. Wang,et al.  Colorectal carcinoma: Pathologic aspects. , 2012, Journal of gastrointestinal oncology.

[78]  I. Nagtegaal,et al.  Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. , 2012, European journal of cancer.

[79]  T. Limpaiboon,et al.  A novel TFF2 splice variant (ΔEX2TFF2) correlates with longer overall survival time in cholangiocarcinoma , 2011, Oncology reports.

[80]  Yie Yang,et al.  Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer , 2011, Oncology reports.

[81]  Javier Sastre,et al.  Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior , 2012, BMC Cancer.

[82]  Joshua M. Stuart,et al.  Subtype and pathway specific responses to anticancer compounds in breast cancer , 2011, Proceedings of the National Academy of Sciences.

[83]  T. Wang,et al.  Trefoil Factor 2 Requires Na/H Exchanger 2 Activity to Enhance Mouse Gastric Epithelial Repair* , 2011, The Journal of Biological Chemistry.

[84]  M. Kaminishi,et al.  Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. , 2011, Gastroenterology.

[85]  M. Washington,et al.  Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. , 2011, The Journal of clinical investigation.

[86]  A. Deal,et al.  STT3A, C1orf24, TFF3: Putative Markers for Characterization of Follicular Thyroid Neoplasms From Fine‐Needle Aspirates , 2011, The Laryngoscope.

[87]  P. Jiang,et al.  Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2 , 2011, Cellular and Molecular Life Sciences.

[88]  P. Spellman,et al.  Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.

[89]  Xiao-Fan Wang,et al.  Trefoil factor 1 acts to suppress senescence induced by oncogene activation during the cellular transformation process , 2011, Proceedings of the National Academy of Sciences.

[90]  T. Limpaiboon,et al.  Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. , 2011, World journal of gastroenterology.

[91]  H. Tomita,et al.  Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. , 2011, Gastroenterology.

[92]  B. Reina-San-Martin,et al.  Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice , 2011, Oncogene.

[93]  S. Poulsen,et al.  Trefoil factor family peptides in the human foetus and at birth , 2011, European journal of clinical investigation.

[94]  E. Meese,et al.  Profiling of regulatory microRNA transcriptomes in various biological processes: a review , 2011, Journal of Applied Genetics.

[95]  T. Wang,et al.  TFF2 mRNA transcript expression marks a gland progenitor cell of the gastric oxyntic mucosa. , 2010, Gastroenterology.

[96]  K. D. Sørensen,et al.  Promoter hypomethylation and upregulation of trefoil factors in prostate cancer , 2010, International journal of cancer.

[97]  Jun S. Song,et al.  Negative regulation of tumor suppressor p53 by microRNA miR-504. , 2010, Molecular cell.

[98]  S. Müller,et al.  Human intestinal TFF3 forms disulfide-linked heteromers with the mucus-associated FCGBP protein and is released by hydrogen sulfide. , 2010, Journal of proteome research.

[99]  J. Alsina,et al.  Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. , 2010, Gastroenterology.

[100]  B. Reid,et al.  Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis , 2010, Nature Reviews Cancer.

[101]  S. Karam.  Mouse models demonstrating the role of stem/progenitor cells in gastric carcinogenesis. , 2010, Frontiers in bioscience.

[102]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[103]  Bahram Parvin,et al.  Prediction of epigenetically regulated genes in breast cancer cell lines , 2010, BMC Bioinformatics.

[104]  Werner Hoffmann,et al.  Trefoil factor family (TFF) peptides and chemokine receptors: a promising relationship. , 2009, Journal of medicinal chemistry.

[105]  T. Zhu,et al.  Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells. , 2009, Endocrinology.

[106]  D. Peterson,et al.  Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[107]  T. Wang,et al.  p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[108]  Albertha J. M. Walhout,et al.  The interplay between transcription factors and microRNAs in genome‐scale regulatory networks , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[109]  S. Hanash,et al.  A Compendium of Potential Biomarkers of Pancreatic Cancer , 2009, PLoS medicine.

[110]  T. Wang,et al.  Secreted Trefoil Factor 2 Activates the CXCR4 Receptor in Epithelial and Lymphocytic Cancer Cell Lines* , 2009, Journal of Biological Chemistry.

[111]  Hiroyuki Takahashi,et al.  Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis , 2009, Virchows Archiv.

[112]  S. Sel,et al.  Intestinal Trefoil Factor/TFF3 Promotes Re-epithelialization of Corneal Wounds* , 2008, Journal of Biological Chemistry.

[113]  W. Hoffmann.  TFF (trefoil factor family) peptides and their potential roles for differentiation processes during airway remodeling. , 2007, Current medicinal chemistry.

[114]  L. Thim,et al.  Tissue Localization of Human Trefoil Factors 1, 2, and 3 , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[115]  O. Huber,et al.  TFF3-peptide increases transepithelial resistance in epithelial cells by modulating claudin-1 and -2 expression , 2006, Peptides.

[116]  S. Poulsen,et al.  Systemically administered trefoil factors are secreted into the gastric lumen and increase the viscosity of gastric contents , 2006, British journal of pharmacology.

[117]  D. Podolsky,et al.  Vangl1 Protein Acts as a Downstream Effector of Intestinal Trefoil Factor (ITF)/TFF3 Signaling and Regulates Wound Healing of Intestinal Epithelium* , 2006, Journal of Biological Chemistry.

[118]  S. Poulsen,et al.  Plasma Levels of Trefoil Factors are Increased in Patients with Advanced Prostate Cancer , 2006, Clinical Cancer Research.

[119]  W. Hoffmann.  Trefoil factors , 2005, Cellular and Molecular Life Sciences CMLS.

[120]  F. May,et al.  Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C. , 2005, Biochemistry.

[121]  S. Powell,et al.  Transcriptional repression of TFF1 in gastric epithelial cells by CCAAT/enhancer binding protein-beta. , 2005, Biochimica et biophysica acta.

[122]  S. Poulsen,et al.  Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat , 2005, Regulatory Peptides.

[123]  Lin Li,et al.  Estrogen regulation of trefoil factor 1 expression by estrogen receptor α and Sp proteins , 2005 .

[124]  Jing Lin,et al.  Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells , 2005, Clinical & Experimental Metastasis.

[125]  L. Thim,et al.  Trefoil factors , 2005, Cellular and Molecular Life Sciences CMLS.

[126]  C. Tomasetto,et al.  Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors , 2004, Gut.

[127]  E. Remaut,et al.  Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. , 2004, Gastroenterology.

[128]  G. Stamp,et al.  TFF2 (trefoil family factor2) inhibits apoptosis in breast and colorectal cancer cell lines , 2004, Peptides.

[129]  O. Huber,et al.  Molecular mechanisms involved in TFF3 peptide-mediated modulation of the E-cadherin/catenin cell adhesion complex , 2004, Peptides.

[130]  T. Wang,et al.  Characterization of a CCAAT-enhancer element of trefoil factor family 2 (TFF2) promoter in MCF-7 cells , 2004, Peptides.

[131]  J. Jónasson,et al.  Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) Associated with Gastric Cancer in Iceland , 2003, Digestive Diseases and Sciences.

[132]  R. Poulsom,et al.  The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide , 1994, The Histochemical Journal.

[133]  D. Taupin,et al.  Trefoil factors: initiators of mucosal healing , 2003, Nature Reviews Molecular Cell Biology.

[134]  J. Udagawa,et al.  Expression of Cytoplasmic TFF2 Is a Marker of Tumor Metastasis and Negative Prognostic Factor in Gastric Cancer , 2003, Laboratory Investigation.

[135]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[136]  N. Blin,et al.  Tumour necrosis factor α and nuclear factor κB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide , 2003 .

[137]  S. Major,et al.  The closely related estrogen-regulated trefoil proteins TFF1 and TFF3 have markedly different hydrodynamic properties, overall charge, and distribution of surface charge. , 2003, Biochemistry.

[138]  C. Iacobuzio-Donahue,et al.  Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. , 2003, Cancer research.

[139]  S. Powell,et al.  Magnetic resonance imaging of gastric cancer in Tff1 knock‐out mice , 2003, Magnetic resonance in medicine.

[140]  M. Mareel,et al.  Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase‐2 and EGF receptor signaling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[141]  F. Paulsen,et al.  TFF peptides in the human efferent tear ducts. , 2002, Investigative ophthalmology & visual science.

[142]  L. Thim,et al.  Effect of trefoil factors on the viscoelastic properties of mucus gels , 2002, European journal of clinical investigation.

[143]  R. Raychowdhury,et al.  Autoinduction of the trefoil factor 2 (TFF2) promoter requires an upstream cis-acting element. , 2002, Biochemical and biophysical research communications.

[144]  T. Wang,et al.  TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. , 2002, The Journal of clinical investigation.

[145]  W. Jagla,et al.  Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. , 2002, International review of cytology.

[146]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[147]  V. Gouyer,et al.  Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype. , 2001, Biochimica et biophysica acta.

[148]  Mark A. Williams,et al.  The solution structure of the disulphide‐linked homodimer of the human trefoil protein TFF1 , 2001, FEBS letters.

[149]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[150]  L. Thim,et al.  Isolation and characterization of putative trefoil peptide receptors , 2000, Regulatory Peptides.

[151]  R. Poulsom,et al.  Trefoil factor expression in normal and diseased human salivary glands. , 2000, Human pathology.

[152]  J. Newton,et al.  The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach , 2000, Gut.

[153]  K. Botzenhart,et al.  Trefoil factor family domain peptides in the human respiratory tract , 2000, The Journal of pathology.

[154]  H. Itoh,et al.  Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. , 2000, Gastroenterology.

[155]  C. Tomasetto,et al.  pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. , 2000, Gastroenterology.

[156]  L. Thim,et al.  The trefoil peptides TFF2 and TFF3 are expressed in rat lymphoid tissues and participate in the immune response , 1999, FEBS letters.

[157]  D. Podolsky,et al.  Goblet-cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of complex series of positive and negative regulatory elements. , 1999, The Biochemical journal.

[158]  Scott R. Presnell,et al.  Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[159]  W. Bodmer,et al.  Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells , 1998 .

[160]  G. Stamp,et al.  Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co‐expressed in normal, hyperplastic, and neoplastic human breast epithelium , 1997, The Journal of pathology.

[161]  W. Hsueh,et al.  Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting. , 1997, Biochemical and biophysical research communications.

[162]  S. Safe,et al.  Identification of a motif within the 5' regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression. , 1997, Biochemistry.

[163]  Y Lasne,et al.  Involvement of DNA methylation in the control of the expression of an estrogen‐induced breast‐cancer‐associated protein (pS2) in human breast cancers , 1997, Journal of cellular biochemistry.

[164]  R. Poulsom,et al.  Trefoil peptides , 1999, Bailliere's clinical gastroenterology.

[165]  T. Zetzsche,et al.  Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[166]  M. Fishman,et al.  Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor , 1996, Science.

[167]  P. Chambon,et al.  Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.

[168]  H. Shizuya,et al.  Cloning of contiguous genomic fragments from human chromosome 21 harbouring three trefoil peptide genes , 1996, Human Genetics.

[169]  L. Thim,et al.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. , 1995, Gastroenterology.

[170]  R. Playford,et al.  Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. , 1995, Gastroenterology.

[171]  R. Poulsom,et al.  Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. , 1993, Gastroenterology.

[172]  R. Poulsom,et al.  hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[173]  R. Poulsom,et al.  The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in ‘gastric metaplasia’ of the proximal duodenum: Implications for the nature of ‘gastric metaplasia’ , 1993, The Journal of pathology.

[174]  D. Podolsky,et al.  Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[175]  R. Lathe,et al.  Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. , 1991, Gastroenterology.

[176]  P Chambon,et al.  The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c‐Ha‐ras oncoprotein and the c‐jun protein. , 1989, The EMBO journal.

[177]  R. Lathe,et al.  Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. , 1988, Science.

[178]  P. Chambon,et al.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. , 1982, Nucleic acids research.

[179]  L. Thim,et al.  Pancreatic Spasmolytic Polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects , 1982, Regulatory Peptides.